Sex differences and adherence of patients treated with wearable cardioverter-defibrillator

• Verfasst von: Abumayyaleh, Mohammad S. A. [VerfasserIn]
• Verfasst von: Dreher, Tobias C. [VerfasserIn]
• Verfasst von: Rosenkaimer, Stephanie L. [VerfasserIn]
• Verfasst von: Röger, Susanne [VerfasserIn]
• Verfasst von: Erath, Julia W. [VerfasserIn]
• Verfasst von: Klein, Norbert [VerfasserIn]
• Verfasst von: Kovacs, Boldizsar [VerfasserIn]
• Verfasst von: Duru, Firat [VerfasserIn]
• Verfasst von: Saguner, Ardan M. [VerfasserIn]
• Verfasst von: El-Battrawy, Ibrahim [VerfasserIn]
• Verfasst von: Akın, Ibrahim [VerfasserIn]
• Titel: Sex differences and adherence of patients treated with wearable cardioverter-defibrillator
• Titelzusatz: insights from an international multicenter register
• Verf.angabe: Mohammad Abumayyaleh, Tobias C. Dreher, Stephanie Rosenkaimer, Susanne Röger, Julia W. Erath, Norbert Klein, Boldizsar Kovacs, Firat Duru, Ardan M. Saguner, Ibrahim El-Battrawy, Ibrahim Akin
• E-Jahr: 2022
• Jahr: 05 August 2022
• Umfang: 7 S.
• Fussnoten: Gesehen am 03.07.2023
• Titel Quelle: Enthalten in: Journal of cardiovascular electrophysiology
• Ort Quelle: Oxford : Wiley-Blackwell, 1990
• Jahr Quelle: 2022
• Band/Heft Quelle: 33(2022), 11, Seite 2243-2249
• ISSN Quelle: 1540-8167
• DOI: doi:10.1111/jce.15648
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: female
• Sach-SW: male
• Sach-SW: sex differences
• Sach-SW: sudden cardiac death
• Sach-SW: wearable cardioverter-defibrillator
• K10plus-PPN: 1851410694
• K10plus-PPN:
  Universitätsbibliothek
• Lokale URL UB: Zum Volltext

Abstract

Aims: Treatment with the wearable cardioverter defibrillator (WCD) may protect against sudden cardiac death (SCD) as a bridging therapy until a cardioverter-defibrillator may be implanted. We analyzed in a multicenter setting a consecutive patient cohort wearing WCD to explore sex differences. Methods and Results: We analyzed 708 consecutive patients, 579 (81.8%) from whom were males and 129 (18.2%) females (age, 60.5 ± 14 vs. 61.6 ± 17 years old; p = .44). While the rate of ischemic cardiomyopathy (ICM) as a cause of prescription of WCD was significantly higher in males as compared to females (42.7% vs. 26.4%; p = .001), females received it more frequently due to nonischemic cardiomyopathy (NICM) (55.8% vs. 42.7%); p = .009). The wear time of WCD was equivalent in both groups (21.1 ± 4.3 h/days in males vs. 21.5 ± 4.4 h/days in females; p = .27; and 62.6 ± 44.3 days in males vs. 56.5 ± 39 days in females; p = .15). Mortality was comparable in both groups at 2-year-follow-up (6.8% in males vs. 9.7% in females; p = .55). Appropriate WCD shocks and the incidence of ICD implantations were similar in both groups (2.4% in males vs. 3.9% in females; p = .07) (35.1% in males vs. 31.8% in females; p = .37), respectively. In age tertile analysis, compliance was observed more in 73-91 years old group as compared with 14-51 years old group (87.8% vs. 68.3%; p < .001). Conclusion: Compliance for wearing WCD was excellent regardless of sex. Furthermore, mortality and the incidence of ICD implantations were comparable in both sexes. Appropriate WCD shocks were similar in both sexes.